Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations

Lavin, Michelle; T. Elder, Patrick; O’Keeffe, Denis; Enright, Helen; Ryan, Eileen; Kelly, Anna; El Hassadi, Ezzat; McNicholl, Feargal; Benson, Gary; Lê, Giao; Byrne, Mary; Ryan, Kevin; O’Connell, Niamh; S. O’Donnell, James

doi:10.1111/bjh.17613

Public

Vaccine‐induced immune thrombotic thrombocytopenia (VITT) – a novel clinico‐pathological entity with heterogeneous clinical presentations

Published in British Journal of Haematology • Jun 22, 2021

Authors:

Michelle Lavin

Patrick T. Elder

Denis O’Keeffe

Abstract

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a novel entity that emerged in March 2021 following reports of unusual thrombosis after ChAdOx1 nCoV-19, (AstraZeneca) vaccination. Following the recognition of this syndrome, multiple consensus guidelines have been released to risk strati...

Subject

Medicine

Pathological

Immune thrombocytopenia

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!